Published in Cancer Lett on September 14, 2008
The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene (2009) 2.72
Cytokines, inflammation and colon cancer. Curr Cancer Drug Targets (2011) 1.38
The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models. J Gastroenterol (2012) 1.20
Tumor formation in a mouse model of colitis-associated colon cancer does not require COX-1 or COX-2 expression. Carcinogenesis (2010) 1.15
Hypoxia-inducible factor-2α is essential in activating the COX2/mPGES-1/PGE2 signaling axis in colon cancer. Carcinogenesis (2012) 0.97
Interactions between diet, lifestyle and IL10, IL1B, and PTGS2/COX-2 gene polymorphisms in relation to risk of colorectal cancer in a prospective Danish case-cohort study. PLoS One (2013) 0.94
The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer. Cancers (Basel) (2011) 0.92
Effect of cyclooxygenase genotype and dietary fish oil on colonic eicosanoids in mice. J Nutr Biochem (2011) 0.87
Can licorice lick colon cancer? J Clin Invest (2009) 0.85
Deficiency of phospholipase A2 group 7 decreases intestinal polyposis and colon tumorigenesis in Apc(Min/+) mice. Cancer Res (2013) 0.84
Cyclooxygenase 2-dependent and independent activation of Akt through casein kinase 2α contributes to human bladder cancer cell survival. BMC Urol (2011) 0.84
Epithelial-specific deletion of 11β-HSD2 hinders Apcmin/+ mouse tumorigenesis. Mol Cancer Res (2013) 0.79
Effect of fish oil on levels of R- and S-enantiomers of 5-, 12-, and 15-hydroxyeicosatetraenoic acids in mouse colonic mucosa. Nutr Cancer (2011) 0.78
The Hen or the Egg: Inflammatory Aspects of Murine MPN Models. Mediators Inflamm (2015) 0.76
Epigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition. Oncotarget (2016) 0.75
Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med (2007) 9.04
Aspirin use and reduced risk of fatal colon cancer. N Engl J Med (1991) 7.85
Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42
Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology (2003) 4.10
Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem (2001) 3.69
Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med (2002) 3.47
Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest (2000) 3.03
Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem (2003) 2.65
Clonogenic growth of epithelial cells from normal colonic mucosa from both mice and humans. Gastroenterology (1999) 2.23
The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships. J Biol Chem (1987) 2.13
Mechanisms underlying generation of gradients in gene expression within the intestine: an analysis using transgenic mice containing fatty acid binding protein-human growth hormone fusion genes. Genes Dev (1988) 2.01
Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol (2005) 1.98
Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2. Gut (1994) 1.72
Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2007) 1.71
Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade. Cancer Res (2005) 1.68
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc Natl Acad Sci U S A (2002) 1.61
Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation. J Clin Invest (2004) 1.59
Prostaglandin E2 stimulates the growth of colon cancer cells via induction of amphiregulin. Cancer Res (2003) 1.48
Role of cyclooxygenase-2 in colorectal cancer. Cancer Metastasis Rev (2004) 1.41
EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival. Oncogene (2006) 1.37
The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia. Cancer Res (2005) 1.33
HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Cancer Res (2005) 1.32
Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. FASEB J (2003) 1.29
Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism. Cancer Res (2006) 1.28
Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest (1997) 1.25
Azoxymethane is a genetic background-dependent colorectal tumor initiator and promoter in mice: effects of dose, route, and diet. Toxicol Sci (2005) 1.21
Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets. Mol Cancer Ther (2006) 1.15
Prostaglandin E2 synergistically enhances receptor tyrosine kinase-dependent signaling system in colon cancer cells. J Biol Chem (2004) 1.14
Dysregulated post-transcriptional control of COX-2 gene expression in cancer. Curr Pharm Des (2004) 1.13
Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res (1997) 1.13
COX-2 in play at the AHA and the FDA. Trends Pharmacol Sci (2007) 1.09
Aspirin and the prevention of colorectal cancer. N Engl J Med (2003) 1.08
Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J Immunol (1998) 1.05
Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis (2003) 0.95
Tumor promotion as a target of cancer prevention. Recent Results Cancer Res (2007) 0.94
Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes. Hepatology (2007) 0.94
Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-alpha converting enzyme. Cell Signal (2007) 0.91
Tumor formation is correlated with expression of beta-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice. Cancer Sci (2004) 0.85
A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet (2006) 9.56
Disruption of diacylglycerol metabolism impairs the induction of T cell anergy. Nat Immunol (2006) 2.43
Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins. Science (2007) 2.25
Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol (2002) 2.16
Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res (2002) 2.10
Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell (2008) 1.97
DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN. J Am Soc Nephrol (2012) 1.93
APC-dependent suppression of colon carcinogenesis by PPARgamma. Proc Natl Acad Sci U S A (2002) 1.89
The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effect. J Acquir Immune Defic Syndr (2007) 1.84
Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J Biol Chem (2005) 1.73
The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med (2002) 1.66
Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors. Int J Oncol (2003) 1.60
Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1. J Exp Med (2003) 1.58
Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. Cancer Res (2008) 1.54
Regulation and functions of diacylglycerol kinases. Chem Rev (2011) 1.48
Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands. Curr Opin Hematol (2002) 1.43
Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci (2003) 1.39
Planar spindle orientation and asymmetric cytokinesis in the mouse small intestine. J Histochem Cytochem (2007) 1.37
Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates. Circulation (2005) 1.33
Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine. Eur J Pharmacol (2002) 1.30
HDAC3 overexpression and colon cancer cell proliferation and differentiation. Mol Carcinog (2008) 1.29
The role of cyclooxygenase-2 and prostaglandins in colon cancer. Prostaglandins Other Lipid Mediat (2006) 1.29
Multifaceted roles of PGE2 in inflammation and cancer. Semin Immunopathol (2012) 1.29
Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2. J Lipid Res (2012) 1.28
Diacylglycerol kinase zeta regulates actin cytoskeleton reorganization through dissociation of Rac1 from RhoGDI. Mol Biol Cell (2009) 1.28
Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression. Cancer Res (2006) 1.26
Diacylglycerol kinases. Cell Signal (2004) 1.25
The p50-p50 NF-kappaB complex as a stimulus-specific repressor of gene activation. Mol Cell Biochem (2004) 1.23
The emerging roles of PAF acetylhydrolase. J Lipid Res (2008) 1.22
Diacylglycerol kinase iota regulates Ras guanyl-releasing protein 3 and inhibits Rap1 signaling. Proc Natl Acad Sci U S A (2005) 1.21
New perspectives on APC control of cell fate and proliferation in colorectal cancer. Cell Cycle (2009) 1.21
Diacylglycerol kinase delta regulates protein kinase C and epidermal growth factor receptor signaling. Proc Natl Acad Sci U S A (2006) 1.20
Regulation of T cell receptor-induced activation of the Ras-ERK pathway by diacylglycerol kinase zeta. J Biol Chem (2002) 1.20
Cell-cell interactions: leukocyte-endothelial interactions. Curr Opin Hematol (2003) 1.19
Roles of cPLA2alpha and arachidonic acid in cancer. Biochim Biophys Acta (2006) 1.19
Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J Clin Invest (2006) 1.18
Sol Sherry lecture in thrombosis: molecular events in acute inflammation. Arterioscler Thromb Vasc Biol (2002) 1.16
Association between 5-lipoxygenase expression and plaque instability in humans. Arterioscler Thromb Vasc Biol (2005) 1.15
Function and regulation of retinoic acid-inducible gene-I. Crit Rev Immunol (2010) 1.15
HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling. Cancer Biol Ther (2008) 1.13
Association of diacylglycerol kinase zeta with protein kinase C alpha: spatial regulation of diacylglycerol signaling. J Cell Biol (2003) 1.11
Diacylglycerol kinase epsilon is selective for both acyl chains of phosphatidic acid or diacylglycerol. J Biol Chem (2009) 1.10
Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Shock (2006) 1.09
Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2. Biochem Biophys Res Commun (2002) 1.08
Dramatic differences in the roles in lipid metabolism of two isoforms of diacylglycerol kinase. Biochemistry (2008) 1.08
Identification of a domain that mediates association of platelet-activating factor acetylhydrolase with high density lipoprotein. J Biol Chem (2008) 1.08
Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability. Oncogene (2004) 1.08
Expression of Long-chain Fatty Acyl-CoA Synthetase 4 in Breast and Prostate Cancers Is Associated with Sex Steroid Hormone Receptor Negativity. Transl Oncol (2010) 1.08
mPGES-1 as a target for cancer suppression: A comprehensive invited review "Phospholipase A2 and lipid mediators". Biochimie (2010) 1.07
Deoxycholic acid promotes the growth of colonic aberrant crypt foci. Mol Carcinog (2007) 1.06
Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer. Cancer Res (2004) 1.04
Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitis. Carcinogenesis (2010) 1.04
Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity. Cancer Prev Res (Phila) (2011) 1.03
Worldwide child and adolescent mental health begins with awareness: a preliminary assessment in nine countries. Int Rev Psychiatry (2008) 1.02
Role of Notch signaling in colon homeostasis and carcinogenesis. Cancer Sci (2011) 1.02
IFN-epsilon mediates TNF-alpha-induced STAT1 phosphorylation and induction of retinoic acid-inducible gene-I in human cervical cancer cells. J Immunol (2007) 1.01
Intestinal lineage commitment of embryonic stem cells. Differentiation (2010) 1.01
Protein kinase C alpha phosphorylates and negatively regulates diacylglycerol kinase zeta. J Biol Chem (2003) 1.00
Diacylglycerol kinase zeta regulates phosphatidylinositol 4-phosphate 5-kinase Ialpha by a novel mechanism. Cell Signal (2004) 1.00
Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}. Cancer Prev Res (Phila) (2011) 1.00
Microgenomics: Identification of new expression profiles via small and single-cell sample analyses. Cytometry A (2004) 0.99
Diacylglycerol kinases as sources of phosphatidic acid. Biochim Biophys Acta (2009) 0.99
The adenomatous polyposis coli tumor suppressor gene regulates expression of cyclooxygenase-2 by a mechanism that involves retinoic acid. J Biol Chem (2006) 0.99
Synaptic removal of diacylglycerol by DGKzeta and PSD-95 regulates dendritic spine maintenance. EMBO J (2009) 0.98
Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer. Cancer Lett (2006) 0.98
Diacylglycerol kinase-zeta localization in skeletal muscle is regulated by phosphorylation and interaction with syntrophins. Mol Biol Cell (2003) 0.98
Fish oil fix. Nat Med (2005) 0.97
Dual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis. Pediatr Res (2010) 0.97
Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis. Cancer Res (2005) 0.96
Regulation of neurite outgrowth in N1E-115 cells through PDZ-mediated recruitment of diacylglycerol kinase zeta. Mol Cell Biol (2005) 0.95
Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies. Cancer Lett (2006) 0.95
Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis (2003) 0.95
Role of the hydrophobic segment of diacylglycerol kinase epsilon. Biochemistry (2007) 0.95
DGKι regulates presynaptic release during mGluR-dependent LTD. EMBO J (2010) 0.94
Determination of the topology of the hydrophobic segment of mammalian diacylglycerol kinase epsilon in a cell membrane and its relationship to predictions from modeling. J Mol Biol (2008) 0.94
Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics. Clin Pharmacol Ther (2006) 0.94
Retinoic acid inhibits beta-catenin through suppression of Cox-2: a role for truncated adenomatous polyposis coli. J Biol Chem (2007) 0.94
Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer (2007) 0.93
Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy. Cancer Causes Control (2011) 0.93
CD13 is dispensable for normal hematopoiesis and myeloid cell functions in the mouse. J Leukoc Biol (2010) 0.93